Mathew Nicholls, MD
Orthopaedic Surgery · Bellevue, WANPI 1336180413
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Ferring Pharmaceuticals Inc. at 52.0% of the total. Reporting peaked in 2019 at $19,041 and has fallen 94.7% since, to $1,012 in 2025.
Across 72 payments — averaging $466.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$17K
- Medical Device Business Services, Inc.$11K
- Zimmer Biomet$2K
- Johnson & Johnson$1K
- Pacira Pharmaceuticals Incorporated$640
- Stryker$165
- plus $488 from 5 others
What the payments were for
- Consulting fees$14,23542%
- Speaking & faculty fees$13,29840%
- Travel & lodging$8513%
- Food & beverage$5,21816%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 14 | $17,486 |
| Medical Device Business Services, Inc. | 9 | $11,380 |
| Zimmer Biomet | 21 | $2,096 |
| Johnson & Johnson | 14 | $1,345 |
| Pacira Pharmaceuticals Incorporated | 7 | $640 |
| Stryker | 1 | $165 |
| Sanara Medtech Inc. | 1 | $156 |
| Invictus Surgical Incorporated | 1 | $133 |
| Linvatec Corporation | 1 | $107 |
| Heron Therapeutics, Inc. | 1 | $66 |
| Medacta USA, Inc. | 2 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EUFLEXXA$17,106
- MONOVISC$11,238
- ORTHOVISC$11,238
- PEAK$11,115
- Persona$295
- G7$294
- Velys$259
- ROSA$250
- EXPAREL$239
- MAKO$165
- CellerateRx$156
- Quattro$130
- Acetabular$125
- AccuFill$121
- Iovera$114
- Zilretta$114
- IOVERA SYSTEM$113
- LINVATEC KNEE PRESERVATION SYSTEM$107
- LINVATEC SHOULDER ARTHROSCOPY$107
How this compares
$33,601 in reported general payments places this provider in the 85th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Bellevue
- Christopher BooneBellevue$160K
- Ashit PatelBellevue$29K
- William BarrettRenton$7.7M
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Tim LovellSpokane$1.8M
- Timothy AltonRenton$1.5M
- Burt YaszaySeattle$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.